SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-24-010190
Filing Date
2024-03-18
Accepted
2024-03-18 07:35:57
Documents
87
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 1885281
2 ex14.htm EX-14 42450
3 ex19.htm EX-19 65664
4 ex21.htm EX-21 2430
5 ex23-1.htm EX-23.1 3217
6 ex23-2.htm EX-23.2 3074
7 ex31-1.htm EX-31.1 18017
8 ex31-2.htm EX-31.2 18576
9 ex32.htm EX-32 12725
10 ex97.htm EX-97.DESCRIPTION 61945
  Complete submission text file 0001493152-24-010190.txt   8363821

Data Files

Seq Description Document Type Size
11 XBRL SCHEMA FILE abeo-20231231.xsd EX-101.SCH 52997
12 XBRL CALCULATION FILE abeo-20231231_cal.xml EX-101.CAL 83140
13 XBRL DEFINITION FILE abeo-20231231_def.xml EX-101.DEF 272991
14 XBRL LABEL FILE abeo-20231231_lab.xml EX-101.LAB 486168
15 XBRL PRESENTATION FILE abeo-20231231_pre.xml EX-101.PRE 390744
91 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 1159771
Mailing Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103
Business Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103 646-813-4701
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-15771 | Film No.: 24756931
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)